# Evaluation of Diagnostic HIV Ag/Ab Combo Assay

> **NCT00933933** · PHASE3 · COMPLETED · sponsor: **Abbott Diagnostics Division** · enrollment: 635 (actual)

## Conditions studied

- Human Immunodeficiency Viruses

## Interventions

- **DEVICE:** ARCHITECT HIV Ag/Ab Combo
- **DEVICE:** ARCHITECT HIV Ag/Ab Combo

## Key facts

- **NCT ID:** NCT00933933
- **Lead sponsor:** Abbott Diagnostics Division
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-10
- **Final completion:** 2009-11
- **Target enrollment:** 635 (ACTUAL)
- **Last updated:** 2011-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00933933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00933933, "Evaluation of Diagnostic HIV Ag/Ab Combo Assay". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00933933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*